Unison Pharmaceuticals Private Limited
Indian Pharmaceutical Exporter ยท Lipid & Metabolism Specialist ยท $10.6M Total Trade ยท DGFT Verified
Unison Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $10.6M across 4 products in 3 therapeutic categories. Based on 397 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ezetimibe ($5.0M), Apixaban ($3.9M), Rivaroxaban ($1.1M).
Unison Pharmaceuticals Private Limited โ Export Portfolio & Destination Treemap

Who is Unison Pharmaceuticals Private Limited? โ Company Overview & Market Position
Unison Pharmaceuticals Private Limited, established on June 1, 2001, in Ahmedabad, Gujarat, India, is a privately held pharmaceutical company specializing in the development, manufacturing, and marketing of finished pharmaceutical formulations. The company operates under the Corporate Identification Number (CIN) U24232GJ2001PTC079092. As of the financial year ending March 31, 2024, Unison reported a total revenue of โน300.59 crore, reflecting a 29.61% increase from the previous year. The company's authorized capital stands at โน10 crore, with a paid-up capital of โน8.81 crore. Unison employs approximately 1,434 professionals, indicating a robust workforce dedicated to its operations. The registered office is located at Unison House, Nr. Prernatirth Derasar Nr. Ratnadeep-II, Satellite, Jodhpur, Ahmedabad, Gujarat, 380015.